Studies in animals and humans If the work involves human subjects, the author should ensure that the work mentioned has been carried out under The Code (Declaration of Helsinki) of Ethics of the World Medical Association for experiments on humans. The manuscript should be in comply with the Recommendations for the Reporting, Conduct, Editing and Publication of Scholarly Work in Medical Publications and aim to include representative human populations (sex, age and ethnicity) as per those recommendations. The terms gender and sex should be mentioned. Authors have to include declaration that informed consent was gotten as human subjects for experimentation. Also, with observing the privacy rights of human subjects. All animal experiments must comply with the ARRIVE guidelines and should be carried out per the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Research Council's Guide for the Care and Use of Laboratory Animals and the authors should indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the study results. In addition to the contents of the Directive 2010/63/EU, Authors of papers submitted to Octahedron Drug Research are encouraged to reduce as much as possible animal testing. Indeed, animal testing should be limited. Corresponding authors should disclose any relationships with others that could inappropriately affect (bias) the work. Potential conflicts of interest are for example consultancies, employment, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and fundings. All authors, even those without competing interests to declare, should submit the needed data to the corresponding author (which, where relevant, may confirm they have nothing to display). The files should be in a .docx format not be converted to other formats. The work should be described as not published or considered for publication in other journals with exception of the form of a published lecture or academic thesis, an abstract, See "Multiple, redundant or simultaneous publishing" for more information), it is not under consideration for publication elsewhere. Publication has been approved by all authors and implicitly or expressly by the responsible authorities where the work has been carried out and, if accepted, will not be published elsewhere (in the same form) in English or any other language, including electronically without the written consent of the copyright holder. Also, your article may be checked by the originality detection service Crossref Similarity Check.
Preprint posting:
This journal offers its authors a free access for their publication. The corresponding author is expected to get approval from all co-authors before agreeing to release the manuscript publicly online.
You will be told via e-mail when your preprint is posted online and a Digital Object Identifier (DOI) is assigned.
Use inclusive language:
Inclusive language recognizes diversity, conveys respect for all people, takes into account differences, and promotes equal opportunity. The content should not make any assumptions about the beliefs or obligations of any reader; do not contain anything that may imply that one individual is superior to another on the basis of culture, age, gender, race, ethnicity, sexual orientation, disability, or health status; And use inclusive language all the time. Authors must ensure that writing is free from and references to bias, stereotypes, and slang the dominant culture and/or cultural assumptions. We advise to strive for gender neutrality through the use of multiple nouns ("doctors, patients/clients") by default/where possible to avoid using "he, she," or "he/she." We recommend that you avoid using descriptors that refer to personal characteristics such as health status, age, gender, race, ethnicity, culture, sexual orientation, or disability unless they are relevant and valid. When using coding terms, we recommend avoiding offensive or exclusionary terms such as "master," "affiliate," "blacklist," and "whitelist." Instead, we suggest using more convenient and explanatory (subjective) alternatives such as 'primary', 'secondary', 'block list' and 'allow list'. These Guidelines are intended as a point of reference to help determine appropriate language but are by no means exhaustive or definitive.
Contributors:
Each author must declare their individual contribution to the article: all authors must have materially participated in the research and/or article preparation, so roles for all authors should be described. In addition, the statement that all authors have approved the final article should be true and included in the disclosure.
Changes to authorship:
Authors are required to check the list and order of authors carefully before submitting the manuscript. Any rearrangement, addition or deletion of author names in should be made before the manuscript has been accepted and only if the journal Editor approves. To request the Editor to change in the authorship list, the corresponding author should provide: (a) the reason for the change in the author list and (b) written (e-mail, letter) from all authors to confirm that they agree with the addition, removal or rearrangement. In the case of adding or removing authors, this includes confirmation from the author being added or removed.